Chronic Disease Management

FDA Approves Drug for Open-Angle Glaucoma and Ocular Hypertension

by Veronica Salib

In a recent press release, Santen announced that the FDA approved OMLONTI, the company’s newest ophthalmic medication. This ophthalmic solution is composed of 0.002% omidenepag isopropyl. This...

Drug Costs Are Not Justified by Research and Development Costs

by Veronica Salib

It’s no secret that drug costs in the United States have continued to increase in the past few years. The Kaiser Family Foundation states that between 2019 and 2022, 48% of prescription drugs had...

Fish Oil Supplements Associated with Risk of Atrial Fibrillation

by Veronica Salib

Many vitamins and supplements are readily available over the counter for patient use. Understanding the effects of supplements on healthcare can impact and inform physician practices for more effective...

FDA Approves Relyvrio for ALS Treatment

by Veronica Salib

Yesterday, the FDA approved Relyvrio, an ALS drug developed by Amylyx Pharmaceuticals, after extensive discussions about the safety and efficacy of the drug. The drug was initially rejected by an FDA...

How Federal and State Laws Have Hindered Access to OUD Treatment

by Veronica Salib

The opioid epidemic has persisted over the past few decades. Exacerbated by the pharmaceutical industry, this epidemic has left many struggling with opioid use disorder (OUD). Effective treatments for...

How Antirejection Drugs Can Promote Successful Transplants

by Veronica Salib

The United Network for Organ Sharing (UNOS) states that, as of July 2022, there have been 24,414 organ transplants this year in the United States alone. Considering the limitations on the number of organs available for transplant and the...

FDA Approved Psilocybin Investigational New Drug Application

by Veronica Salib

Psilocybin has become increasingly popular in pharmaceutical research to treat multiple neurological and mental health conditions. The FDA recently approved an investigational new drug (IND)...

How Biomarker Research Has Brought Scientists Closer to an HIV Vaccine

by Veronica Salib

In a recent article published in Nature Medicine, researchers shared information on new biomarkers to develop HIV prevention tools. This publication highlighted research from the Antibody Mediated Prevention (AMP) trials. It is thought...

Biosimilars Have Saved $12.6 Billion in the US between 2014 and 2022

by Veronica Salib

Biosimilars are gaining new traction in the pharmaceutical industry as a tool for providers and patients to manage diseases. The National Cancer Institute defines a biosimilar drug as a “biological drug that is very much like another...

Psilocybin-Assisted Psychotherapy Reduces Heavy Drinking

by Veronica Salib

Psilocybin, a chemical compound derived from mushrooms, has been a topic of interest for researchers focused on neuropsychiatric conditions, specifically substance use disorders. A double-blind,...

How Chemotherapy Drugs Impact Cells, Patients, and the Healthcare System

by Veronica Salib

Chemotherapy drugs play a significant role in the treatment of cancer. Understanding the kinds of chemotherapy drugs can help patients make an informed decision with the assistance of their oncologist and their team of healthcare...

FDA Approved the Use of Omnipod 5 for Children Over 2

by Veronica Salib

In January 2022, Omnipod 5 was first approved for anyone over six. Omnipod 5 is the first tubeless automated insulin delivery (AID) made available in the United States for a broad age range. Recently,...

FDA Approved AUVELITY for Major Depressive Disorder in Adults

by Veronica Salib

On August 19, 2022, the FDA approved AUVELITY — an oral medication manufactured by Axsome Therapeutics — for the treatment of major depressive disorder (MDD) in adults. This medication...

Understanding the Burdens of Dialysis

by Veronica Salib

Chronic kidney disease (CKD) occurs when the kidneys fail to filter waste as they typically do in a healthy body. Patients in the late stage of chronic kidney disease progress to end-stage renal failure (ESRF) when they need a transplant...

FDA Approves Cell-Based Gene Therapy for Patients with Beta Thalassemia

by Veronica Salib

On August 17, 2022, the FDA approved bluebird bio's Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy to treat patients with beta thalassemia who need regular red blood...

A History of Insulin Development and Insulin Delivery Systems

by Veronica Salib

In recent years, the costs of prescription drugs have increased dramatically. One of the most notable drugs with high prices is insulin. Understanding the basic uses of insulin and common delivery methods may contribute to an in-depth...

FDA Approves the Sale of Hearing Aids over the Counter

by Veronica Salib

Recently, the FDA approved the sale of some over-the-counter (OTC) hearing aids, widening access to those who need them. According to the National Institute on Deafness and Other Communication...

California Allots $100 Million to Produce Insulin, Improving Access

by Veronica Salib

According to the CDC, patients with type one diabetes have a pancreas that produces no or little insulin. To properly manage the disease, many patients take insulin. With the price of insulin rising,...

A History of Antivirals: Mechanisms, Classes, and Subtypes

by Veronica Salib

Antivirals have rapidly become a popular topic with their implications in treating COVID-19. Understanding antivirals, their mechanisms, classes, and subtypes is an essential part of being able to treat viral infections such as the...

Antibiotic Overprescription Is Associated with Worse CKD Outcomes

by Veronica Salib

A recent study in JAMA Open Network looked at the relationship between fluoroquinolone — an antibiotic — dosage and adverse side effects in patients with CKD. The researchers found that...